Antineoplastic drug effects on spermatogenesis studied by velocity sedimentation cell separation.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002454:Cell Differentiation; D002458:Cell Fractionation; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003584:Cytological Techniques; D066298:In Vitro Techniques; D007930:Leucine / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D011344:Procarbazine / Q000494:pharmacology; D013091:Spermatogenesis / Q000187:drug effects*; D013094:Spermatozoa / Q000166:cytology; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D003561:Cytarabine; D014316:Tritium; D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D007930:Leucine; D013936:Thymidine; D014529:Uridine